RODEL BOBADILLA: Open Payments
NPI 1942312111 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,873 in 89 payments from 18 companies in 2025. Trend: 2023 $2,538 · 2024 $2,339 · 2025 $1,873
Food & beverage: $1,873
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $365 |
| E.R. Squibb & Sons, L.L.C. | 15 | $186 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $132 |
| AstraZeneca Pharmaceuticals LP | 8 | $131 |
| Alnylam Pharmaceuticals Inc. | 5 | $126 |
| AltaThera Pharmaceuticals LLC | 1 | $125 |
| Philips North America LLC | 4 | $107 |
| Amgen Inc. | 6 | $103 |
| PFIZER INC. | 5 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $87 |
Products named: LEQVIO, Kerendia, FARXIGA, CAMZYOS, ONPATTRO, Sotalol Hydrochloride, Repatha, ELIQUIS.
Industry payments across SC — which companies pay providers there.
